vs

Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and Kymera Therapeutics, Inc. (KYMR). Click either name above to swap in a different company.

Kymera Therapeutics, Inc. is the larger business by last-quarter revenue ($11.5M vs $6.0M, roughly 1.9× CHICAGO RIVET & MACHINE CO). CHICAGO RIVET & MACHINE CO runs the higher net margin — -19.3% vs -667.6%, a 648.3% gap on every dollar of revenue. On growth, CHICAGO RIVET & MACHINE CO posted the faster year-over-year revenue change (45.9% vs -55.3%). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-60.6M). Over the past eight quarters, Kymera Therapeutics, Inc.'s revenue compounded faster (10.1% CAGR vs -12.7%).

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

Kymera Therapeutics is a clinical-stage biopharmaceutical company specialized in developing innovative targeted protein degradation therapies. It advances a diversified pipeline of drug candidates targeting previously undruggable proteins to address unmet medical needs in oncology, autoimmune and inflammatory diseases worldwide.

CVR vs KYMR — Head-to-Head

Bigger by revenue
KYMR
KYMR
1.9× larger
KYMR
$11.5M
$6.0M
CVR
Growing faster (revenue YoY)
CVR
CVR
+101.1% gap
CVR
45.9%
-55.3%
KYMR
Higher net margin
CVR
CVR
648.3% more per $
CVR
-19.3%
-667.6%
KYMR
More free cash flow
CVR
CVR
$60.6M more FCF
CVR
$24.3K
$-60.6M
KYMR
Faster 2-yr revenue CAGR
KYMR
KYMR
Annualised
KYMR
10.1%
-12.7%
CVR

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CVR
CVR
KYMR
KYMR
Revenue
$6.0M
$11.5M
Net Profit
$-1.2M
$-76.6M
Gross Margin
2.7%
Operating Margin
-15.3%
-736.8%
Net Margin
-19.3%
-667.6%
Revenue YoY
45.9%
-55.3%
Net Profit YoY
68.0%
-82.1%
EPS (diluted)
$-0.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVR
CVR
KYMR
KYMR
Q4 25
$6.0M
Q3 25
$7.4M
Q2 25
$7.3M
$11.5M
Q1 25
$7.2M
$22.1M
Q4 24
$4.1M
$7.4M
Q3 24
$7.0M
Q2 24
$8.1M
$25.6M
Q1 24
$7.9M
$10.3M
Net Profit
CVR
CVR
KYMR
KYMR
Q4 25
$-1.2M
Q3 25
$67.6K
Q2 25
$-395.0K
$-76.6M
Q1 25
$401.0K
$-65.6M
Q4 24
$-3.6M
$-70.8M
Q3 24
$-1.4M
Q2 24
$142.1K
$-42.1M
Q1 24
$-698.0K
$-48.6M
Gross Margin
CVR
CVR
KYMR
KYMR
Q4 25
2.7%
Q3 25
18.1%
Q2 25
13.4%
Q1 25
22.9%
Q4 24
-43.7%
Q3 24
10.0%
Q2 24
17.6%
Q1 24
9.5%
Operating Margin
CVR
CVR
KYMR
KYMR
Q4 25
-15.3%
Q3 25
0.9%
Q2 25
-5.7%
-736.8%
Q1 25
1.0%
-336.8%
Q4 24
-86.4%
-1092.2%
Q3 24
-11.8%
Q2 24
1.3%
-198.5%
Q1 24
-11.5%
-562.2%
Net Margin
CVR
CVR
KYMR
KYMR
Q4 25
-19.3%
Q3 25
0.9%
Q2 25
-5.4%
-667.6%
Q1 25
5.5%
-296.7%
Q4 24
-88.0%
-956.9%
Q3 24
-20.8%
Q2 24
1.8%
-164.0%
Q1 24
-8.9%
-472.0%
EPS (diluted)
CVR
CVR
KYMR
KYMR
Q4 25
Q3 25
Q2 25
$-0.95
Q1 25
$-0.82
Q4 24
$-0.89
Q3 24
Q2 24
$-0.58
Q1 24
$-0.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVR
CVR
KYMR
KYMR
Cash + ST InvestmentsLiquidity on hand
$1.7M
$335.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$18.8M
$971.5M
Total Assets
$23.3M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVR
CVR
KYMR
KYMR
Q4 25
$1.7M
Q3 25
$1.7M
Q2 25
$1.2M
$335.8M
Q1 25
$765.6K
$90.0M
Q4 24
$2.2M
$120.3M
Q3 24
$2.2M
Q2 24
$2.6M
$67.6M
Q1 24
$2.7M
$93.5M
Total Debt
CVR
CVR
KYMR
KYMR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CVR
CVR
KYMR
KYMR
Q4 25
$18.8M
Q3 25
$20.0M
Q2 25
$20.0M
$971.5M
Q1 25
$20.4M
$786.2M
Q4 24
$20.0M
$835.6M
Q3 24
$23.7M
Q2 24
$25.2M
$684.9M
Q1 24
$25.2M
$711.2M
Total Assets
CVR
CVR
KYMR
KYMR
Q4 25
$23.3M
Q3 25
$24.0M
Q2 25
$23.6M
$1.1B
Q1 25
$24.1M
$918.3M
Q4 24
$23.4M
$978.0M
Q3 24
$26.4M
Q2 24
$27.3M
$826.0M
Q1 24
$27.8M
$868.3M
Debt / Equity
CVR
CVR
KYMR
KYMR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVR
CVR
KYMR
KYMR
Operating Cash FlowLast quarter
$116.4K
$-59.9M
Free Cash FlowOCF − Capex
$24.3K
$-60.6M
FCF MarginFCF / Revenue
0.4%
-527.9%
Capex IntensityCapex / Revenue
1.5%
6.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.6M
$-250.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVR
CVR
KYMR
KYMR
Q4 25
$116.4K
Q3 25
$638.0K
Q2 25
$28.2K
$-59.9M
Q1 25
$-2.0M
$-79.2M
Q4 24
$-60.1K
$-61.8M
Q3 24
$-58.2K
Q2 24
$363.5K
$-42.9M
Q1 24
$-398.8K
$-39.6M
Free Cash Flow
CVR
CVR
KYMR
KYMR
Q4 25
$24.3K
Q3 25
$492.1K
Q2 25
$-22.8K
$-60.6M
Q1 25
$-2.1M
$-79.6M
Q4 24
$-118.1K
$-62.7M
Q3 24
$-368.9K
Q2 24
$58.0K
$-47.6M
Q1 24
$-491.8K
$-47.0M
FCF Margin
CVR
CVR
KYMR
KYMR
Q4 25
0.4%
Q3 25
6.7%
Q2 25
-0.3%
-527.9%
Q1 25
-28.3%
-360.3%
Q4 24
-2.9%
-848.3%
Q3 24
-5.3%
Q2 24
0.7%
-185.7%
Q1 24
-6.3%
-456.8%
Capex Intensity
CVR
CVR
KYMR
KYMR
Q4 25
1.5%
Q3 25
2.0%
Q2 25
0.7%
6.1%
Q1 25
0.6%
2.1%
Q4 24
1.4%
12.7%
Q3 24
4.5%
Q2 24
3.8%
18.3%
Q1 24
1.2%
72.0%
Cash Conversion
CVR
CVR
KYMR
KYMR
Q4 25
Q3 25
9.44×
Q2 25
Q1 25
-5.01×
Q4 24
Q3 24
Q2 24
2.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

KYMR
KYMR

Segment breakdown not available.

Related Comparisons